Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Mounjaro beginning to work within the first one to two weeks of their starting dose, though meaningful weight change typically takes four to eight weeks to register on the scales. The medicine starts affecting appetite and blood-sugar regulation from your very first injection, even when the physical effect feels subtle at first. Mounjaro (tirzepatide) is a prescription-only medicine, and a prescriber determines whether it is clinically appropriate for you before treatment begins — our Mounjaro overview explains the full picture of how the medicine works and what the licensed schedule involves.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the first few days after that initial injection. Nothing dramatic has changed on the scales, and you might be wondering whether the medicine is doing anything at all. It is. Tirzepatide begins binding to GIP and GLP-1 receptors in your gut and brain almost immediately, slowing how quickly your stomach empties and beginning to dial down hunger signals. What you're unlikely to feel yet is dramatic weight loss, and that's expected.
The 2.5mg dose exists entirely to reduce early side effects, not to deliver therapeutic weight-loss at full force. Think of it as your system learning to work alongside a new mechanism. The most common early experiences are mild nausea, a slightly earlier sense of fullness at meals, and occasionally some fatigue. Those GI effects (nausea, loose stools, indigestion) are the clearest sign the medicine is active. Many people find them settle within a week or two. If you want a detailed breakdown of how long before Mounjaro kicks in and what to watch for, our FAQs address the early-phase questions our prescribers hear most often.
The short answer to whether it's working: yes, even when you can't yet see it on the scales.
The first dose increase typically happens around week four, moving from 2.5mg to 5mg. This is the point where most people begin noticing a more substantial drop in appetite and, shortly after, a shift on the scales. By weeks eight to twelve, the majority of patients on a titrated programme have recorded visible weight change, often in the region of three to six percent of starting body weight, though the range is genuinely wide.
It is worth knowing that appetite suppression is not always a linear experience. Some people describe a noticeable drop in hunger from week two; others feel the shift more at week six. Neither pattern signals something going wrong. If you are curious about how long until Mounjaro works for different people, the longer timeline of Mounjaro results explores how outcomes evolve across a full treatment course, which is useful reading if you're thinking about what to expect at the three- and six-month marks.
One honest thing to sit with: progress at this stage can feel slower than you hoped, especially if you've read the headline trial figures. Those figures come from 72 weeks of treatment, not the first month. Patience with the titration process pays off.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults with obesity over 72 weeks. At the highest tirzepatide dose, participants lost an average of around 20–21% of body weight. That is a figure worth putting in context: it reflects more than a year of treatment, careful titration, and concurrent lifestyle changes including a reduced-calorie diet and increased physical activity.
NICE's appraisal of tirzepatide (TA1026) cited this evidence base when recommending the medicine for eligible adults. If you're curious about how Mounjaro compares to other licensed options, the weight-loss treatment overview sets out the landscape clearly without overpromising on any individual result.
The NHS medicines page for tirzepatide notes that treatment should be taken alongside a reduced-calorie diet and increased activity, and the trial data supports this: the people who lost the most weight were also making consistent changes to their eating and movement habits. The medicine significantly lowers appetite; what you do with that reduced appetite still matters.
A few things genuinely affect how quickly someone responds. The dose you're on at any given point is probably the biggest factor, early doses are titration steps, not the full therapeutic level. Some people tolerate increases faster than others, and a prescriber may hold a dose for an additional four weeks if side effects are significant. That is not a setback; it is clinical judgment working as it should.
Beyond dose, starting BMI, metabolic rate, existing conditions such as type 2 diabetes, and how much lean muscle you preserve all play a role. People living with insulin resistance sometimes find early weight loss slightly slower before their response accelerates. Hydration and protein intake matter more than many people realise, undereating on protein while appetite is suppressed can mean losing muscle rather than fat, which affects both how you look and how you feel.
If you are wondering how long till Mounjaro kicks in for your own situation, that is exactly the kind of question to raise through a clinical review. Our prescribers review progress at every repeat, it is not just a formality. You can find out how to start treatment through a regulated route, and if you have specific concerns in the meantime, our support team is available seven days a week. When you're ready to take the next step, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.